These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3088852)

  • 1. Nodular goiter: effects of surgery and thyroxine medication.
    Westermark K; Persson CP; Johansson H; Karlsson FA
    World J Surg; 1986 Jun; 10(3):481-7. PubMed ID: 3088852
    [No Abstract]   [Full Text] [Related]  

  • 2. Nodular goiter--is thyroxine medication of any value?
    Persson CP; Johansson H; Westermark K; Karlsson FA
    World J Surg; 1982 Jul; 6(4):391-6. PubMed ID: 6812295
    [No Abstract]   [Full Text] [Related]  

  • 3. Pituitary thyroid recovery following surgery in TRH-unresponsive patients with uni- and multinodular goiter.
    Gemsenjäger E; Staub JJ; Girard J
    Horm Res; 1977; 8(3):139-47. PubMed ID: 409657
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy with L-thyroxine in thyroid struma. Study with ultrasonic evaluation].
    Peta M; Cartasegna S; Fabiani MP; Macchi R; Vecchi G; Costantino D
    Recenti Prog Med; 1989 Jun; 80(6):320-5. PubMed ID: 2672195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
    Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
    Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3).
    Sanchez-Franco F; García MD; Cacicedo L; Martin-Zurro A; Escobar del Ray F; Morreale de Escobar G
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1098-102. PubMed ID: 4208806
    [No Abstract]   [Full Text] [Related]  

  • 8. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
    Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
    Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyrotropin concentrations under basal conditions and after stimulation with thyrotropin-releasing hormone in idiopathic non-toxic goiter.
    Dige-Petersen H; Hummer L
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1115-20. PubMed ID: 406269
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules.
    Morita T; Tamai H; Ohshima A; Komaki G; Matsubayashi S; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Aug; 69(2):227-30. PubMed ID: 2753971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for thyroxine therapy after surgery for nontoxic benign goitre.
    Berglund J; Bondesson L; Christensen SB; Larsson AS; Tibblin S
    Acta Chir Scand; 1990; 156(6-7):433-8. PubMed ID: 2368548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse nontoxic and multinodular goiter.
    Nakhjavani M; Gharib H
    Curr Ther Endocrinol Metab; 1997; 6():109-12. PubMed ID: 9174716
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone suppression therapy in benign nodular goiter].
    Málek Z
    Vnitr Lek; 1996 Sep; 42(9):610-4. PubMed ID: 8984767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of pituitary-thyroid axis after surgical treatment of non-toxic nodular goitre.
    Blichert-Toft M; Egedorf J; Christiansen C; Axelsson CK
    Acta Med Scand; 1979; 206(1-2):15-9. PubMed ID: 113987
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid morphology and function after surgical treatment of thyroid diseases.
    Mann B; Schmale P; Stremmel W
    Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of multinodular goiter in iodine deficiency states].
    Larin OS; Cheren'ko SM; Zhurbyts'ka GO
    Lik Sprava; 2001; (4):29-32. PubMed ID: 11692721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of hyperthyroidism in patients with adenomatous goiter (author's transl)].
    Mori H; Hamada N; Mimura T; Ito K; Momotani N; Nishikawa Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Aug; 56(8):1107-15. PubMed ID: 6774899
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the treatment with L-thyroxine: lack of correspondence between objectives and results].
    Negro R; Dazzi D; Pezzarossa A
    Minerva Endocrinol; 2000 Mar; 25(1):11-7. PubMed ID: 11148845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TSH increase after subtotal thyroidectomy for nontoxic goiter (author's transl)].
    Noel P; Beckers C
    Ann Endocrinol (Paris); 1978; 39(2):163-4. PubMed ID: 99078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.